(Q43113273)

14 November 2017

0 references

Anticitrullinated protein/peptide antibodies in rheumatoid arthritis (English)

1 reference

14 November 2017

Wolfgang L Gross

1

1 reference

14 November 2017

Frank Moosig

series ordinal

2

1 reference

14 November 2017

Peter Lamprecht

series ordinal

3

1 reference

14 November 2017

6 March 2009

1 reference

Deutsches Ärzteblatt international

14 November 2017

1 reference

14 November 2017

106

1 reference

14 November 2017

10

1 reference

14 November 2017

157-158

1 reference

The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695366

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

15 August 2018

1 reference

12 December 2020

Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis

1 reference

12 December 2020

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial

1 reference

12 December 2020

Lessons from a genomewide association study of rheumatoid arthritis

1 reference

12 December 2020

10.3238/ARZTEBL.2009.0157

Identifiers

DOI

1 reference

14 November 2017

1 reference

14 November 2017

PubMed publication ID

19578390

1 reference